Afacifenacin fumarate

TargetMol
Product Code: TAR-T29687
Supplier: TargetMol
CodeSizePrice
TAR-T29687-1mg1mg£352.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T29687-5mg5mg£736.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T29687-10mg10mg£978.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T29687-25mg25mg£1,348.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T29687-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T29687-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Afacifenacin(NS-986 , SMP-986) is a muscarinic receptor antagonist. Afacifenacin has the dual pharmacological effects of both amicinic receptor antagonism (non-selective) and inhibition of bladder afferent pathways by blocking Na+ channels.
CAS:
877606-63-8
Formula:
C31H30F3N3O6
Molecular Weight:
597.591
Pathway:
Neuroscience
Purity:
0.98
SMILES:
OC(=O)C=CC(O)=O.FC(F)(F)Oc1cccc(CN2CCC(CC2)N2[C@@H](c3ccccc3)c3ccccc3NC2=O)c1
Target:
AChR

References

Yeo EK, et al. New therapies in the treatment of overactive bladder. Expert Opin Emerg Drugs. 2013 Sep;18(3):319-37. Natsuko Goto, et al. Dual inhibition of Na+-channel and muscarinic receptor by SMP-986 efficiently improved voiding function compared to anti-muscarinic agents in two conscious rat models of detrusor overactivity. The Journal of Urology. 2008, 179, 129.